119 related articles for article (PubMed ID: 1139855)
1. Plasma levels and symptom complaints in patients maintained on daily dosage of methadone hydrochloride.
Horns WH; Rado M; Goldstein A
Clin Pharmacol Ther; 1975 Jun; 17(6):636-49. PubMed ID: 1139855
[TBL] [Abstract][Full Text] [Related]
2. Plasma testosterone levels in heroin addiction and during methadone maintenance.
Mendelson JH; Mendelson JE; Patch VD
J Pharmacol Exp Ther; 1975 Jan; 192(1):211-17. PubMed ID: 1123724
[TBL] [Abstract][Full Text] [Related]
3. Serum methadone as an aid in managing methadone maintenance patients.
Walton RG; Thornton TL; Wahl GF
Int J Addict; 1978 Jul; 13(5):689-94. PubMed ID: 721328
[TBL] [Abstract][Full Text] [Related]
4. [Methadone treatment and its dangers].
Reingardiene D; Jodziūniene L; Lazauskas R
Medicina (Kaunas); 2009; 45(5):419-25. PubMed ID: 19535889
[TBL] [Abstract][Full Text] [Related]
5. Effects of heroin and methadone on plasma cortisol and testosterone.
Mendelson JH; Meyer RE; Ellingboe J; Mirin SM; McDougle M
J Pharmacol Exp Ther; 1975 Nov; 195(2):296-302. PubMed ID: 1185598
[TBL] [Abstract][Full Text] [Related]
6. Withdrawal from methadone maintenance. Rate of withdrawal and expectation.
Senay EC; Dorus W; Goldberg F; Thornton W
Arch Gen Psychiatry; 1977 Mar; 34(3):361-7. PubMed ID: 843188
[TBL] [Abstract][Full Text] [Related]
7. Case report of barbiturate-induced enhancement of methadone metabolism and withdrawal syndrome.
Liu SJ; Wang RI
Am J Psychiatry; 1984 Oct; 141(10):1287-8. PubMed ID: 6486271
[TBL] [Abstract][Full Text] [Related]
8. Methadone plasma levels and persistent drug abuse in high dose maintenance patients.
Tennant FS; Rawson RA; Cohen A; Tarver A; Clabough D
Subst Alcohol Actions Misuse; 1983; 4(5):369-74. PubMed ID: 6670059
[TBL] [Abstract][Full Text] [Related]
9. Methadone plasma levels and persistent drug abuse in high dose maintenance patients.
Tennant FS; Rawson RA; Cohen A; Tarver A; Clabough D
NIDA Res Monogr; 1984 Mar; 49():262-8. PubMed ID: 6434970
[TBL] [Abstract][Full Text] [Related]
10. The use of serum methadone levels in patients receiving methadone maintenance.
Bell J; Seres V; Bowron P; Lewis J; Batey R
Clin Pharmacol Ther; 1988 Jun; 43(6):623-9. PubMed ID: 3378383
[TBL] [Abstract][Full Text] [Related]
11. Low (40 mg) versus high (80 mg) dose methadone in a 180-day heroin detoxification program.
Banys P; Tusel DJ; Sees KL; Reilly PM; Delucchi KL
J Subst Abuse Treat; 1994; 11(3):225-32. PubMed ID: 8072050
[TBL] [Abstract][Full Text] [Related]
12. Chronic heroin use during methadone treatment: a test of the efficacy of high maintenance doses.
Havassy BE; Tschann JM
Addict Behav; 1984; 9(1):57-65. PubMed ID: 6741668
[TBL] [Abstract][Full Text] [Related]
13. Alpha 1-acid glycoprotein (AAG) and serum protein binding of methadone in heroin addicts with abstinence syndrome.
Garrido MJ; Aguirre C; Trocóniz IF; Marot M; Valle M; Zamacona MK; Calvo R
Int J Clin Pharmacol Ther; 2000 Jan; 38(1):35-40. PubMed ID: 10667835
[TBL] [Abstract][Full Text] [Related]
14. Methadone dose, plasma level, and cross-tolerance to heroin in man.
Volavka J; Verebey K; Resnick R; Mulé S
J Nerv Ment Dis; 1978 Feb; 166(2):104-9. PubMed ID: 627883
[TBL] [Abstract][Full Text] [Related]
15. Population-based pharmacokinetic approach for methadone monitoring of opiate addicts: potential clinical utility.
Wolff K; Rostami-Hodjegan A; Hay AW; Raistrick D; Tucker G
Addiction; 2000 Dec; 95(12):1771-83. PubMed ID: 11177493
[TBL] [Abstract][Full Text] [Related]
16. Control of methadone dosage by patients.
Goldstein A; Hansteen RW; Horns WH
JAMA; 1975 Nov; 234(7):734-7. PubMed ID: 1242455
[TBL] [Abstract][Full Text] [Related]
17. Double-blind detoxification of methadone maintenance patients.
Mintz J; O'Brien CP; O'Hare K; Goldschmidt J
Int J Addict; 1975; 10(5):815-24. PubMed ID: 1176233
[TBL] [Abstract][Full Text] [Related]
18. Utilization of plasma and urine methadone concentrations to optimize treatment in maintenance clinics: I. Measurement techniques for a clinical setting.
Kell MJ
J Addict Dis; 1994; 13(1):5-26. PubMed ID: 8018740
[TBL] [Abstract][Full Text] [Related]
19. Physical symptom complaints of patients on methadone maintenance.
Yaffe GJ; Strelinger RW; Parwatikar S
Proc Natl Conf Methadone Treat; 1973; 1():507-14. PubMed ID: 4808194
[No Abstract] [Full Text] [Related]
20. Methadone dosage, program policies, and heroin use among methadone patients.
Newman RG; Des Jarlais DC
J Subst Abuse Treat; 1992; 9(2):183-4. PubMed ID: 1512805
[No Abstract] [Full Text] [Related]
[Next] [New Search]
